News Archive

https://www.pathology.med.umich.edu/static/apps/cms/1074/Kleer_500x500.jpg

Dr. Celina Kleer Wins ASIP 2020 Outstanding Investigator Award

November 12, 2020 / Asip

Congratulations to Dr. Celina Kleer who was awarded the American Society for Investigative Pathology (ASIP)'s 2020 Outstanding Investigator Award. Dr. Kleer receives the award for her demonstrated excellence in research in experimental pathology [...]

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/1061/Kleer_500x500_2.jpg

Understanding Breast Cancer: My Journey as a Physician-Scientist: Celina Kleer, MD

October 9, 2020 / Events

10:00 am EST

Join us for a virtual event featuring the Department of Pathology's Dr. Celina Kleer, who will host a discussion related to her experiences in understanding breast cancer and her journey as a physician-scientist.

Register Now

FULL STORY

Study from Kleer and Nesvizhskii Labs Reveals the Proteomic Landscape of Metaplastic Breast Carcinomas

May 1, 2020 / Breast Cancer

Along with co-investigators, Sabra Djomehri, a graduate student in Celina Kleer's Laboratory, has discovered the proteomic landscape of metaplastic carcinomas, the most aggressive type of triple negative breast cancer. The study, published in [...]

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/850/Celina-Kleer-7-2019-9-sq.jpg

Kleer honored by the AACR

November 4, 2019 / Rogel Cancer Center

The American Association for Cancer Research announced that Celina Kleer, MD, the Harold A. Oberman Collegiate Professor of Pathology and Director of the Breast Pathology Program, will be the recipient of the 2019 Outstanding Investigator in Breast Cancer Research, supported by the Breast Cancer Research Foundation.

FULL STORY

Asking Tough Questions

July 31, 2018 / Experimental Pathology

Triple-negative breast cancers account for just 15-20% of breast cancers, but a disproportionate number of deaths. A Nature Communications paper from the Kleer Lab, in close collaboration with other U-M Department of Pathology labs, has discovered a reason why and could lead to better outcomes for patients.

Celina Kleer, MD’s lab in the Rogel Cancer Center is occupied by staff and students with a range of experiences and talents, but a common goal – understanding difficult breast cancers [...] 

FULL STORY